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Abstract 
Infestations by ectoparasites are one of the greatest problems in the veterinary practice, due to a large drop in 
performance in cattle herds and other farm animals, generating great economical losses; for pets, besides the 
low quality of life and disruption of homeostasis, ectoparasites represent a risk for transmission of zoonotic 
diseases. The formamidines emerge as a very large group of ectoparasiticides, which its main representative, 
amitraz, is the only one approved for animal use. Amitraz is indicated for animal use against mites, lice, and 
ticks for cattle, swine, and sheep. For dogs, it is used against ticks and mites. However, due to a lack of proper 
orientation and information, reports of accidental intoxications by amitraz, in both animals and humans, are 
not unusual in the literature. Amitraz intoxication has been reported in dogs, and the clinical signs are 
evidenced in the nervous, digestive, cardiovascular, and urinary systems and include sedation, bradycardia, 
bradyarrhythmias, hypotension, bradypnea, transitory hyperglycemia, mydryasis, and hypothermia, cats being 
more sensitive than dogs regarding these last signs. To detect amitraz and its main metabolites, there are many 
standardized methodologies. This review describes the pharmacokinetics, pharmacodinamics, indications, 
toxicological and pathological effects of amitraz, as well as the intoxication treatment and the aspects related 
to its detection in biological matrices. 
Keywords: Formamidines; poisoning; dog; pathology. 
 
Resumo 
As infestações por ectoparasitas representam um dos maiores problemas na rotina da clínica médica 
veterinária, com impactos relacionados à queda no rendimento de animais de produção, gerando graves perdas 
econômicas; para os animais de companhia, além da baixa qualidade de vida e do desequilíbrio da homeostase, 
ectoparasitas representam um risco para a transmissão de zoonoses. As formamidinas surgem como um grupo 
de ectoparasiticidas cujo representante principal, o amitraz, é o único aprovado para uso animal. O amitraz é 
indicado para uso animal contra ácaros, piolhos e carrapatos de bovinos, suínos e ovinos. Para cães, preconiza-
se seu uso contra carrapatos e ácaros. Entretanto, devido à ausência de orientação adequada, os casos de 
intoxicações acidentais por amitraz, tanto em animais como em humanos, são frequentemente relatados. A 
intoxicação por amitraz tem sido relatada em cães, e os sinais clínicos são evidenciados em sistemas nervoso, 
digestivo, cardiovascular e urinário e incluem sedação, bradicardia, bradiarritmias, hipotensão, bradpneia, 
hiperglicemia transitória, midríase e hipotermia, sendo os gatos mais sensíveis do que os cães em relação a 
estes últimos sinais. Para detectar amitraz e seus principais metabólitos, existem muitas metodologias 
padronizadas. Esta revisão descreve a farmacocinética, farmacodinâmica, indicações de uso, efeitos 
toxicológicos e patológicos, além do tratamento da intoxicação e dos aspectos analíticos relacionados à sua 
detecção em matrizes biológicas. 
Palavras-chave: Formamidinas; envenenamento; cão; patologia. 
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Introduction
Parasitism is one of the greatest problems in 
veterinary medicine, especially in hot and wet 
tropical countries (Sartor and Santarém, 2006). 
Ectoparasitism occupy a prominent place among 
the parasitic diseases that affect farm animals, 
raising direct and indirect costs, due to the drop of 
the animals’ yield and the need for a sanitary 
control (Fonseca et al., 2009). Meanwhile, for 
companion animals, the problem is also severe, 
since it directly compromises their welfare, besides 
representing a risk to human health, due to zoonotic 
transmission (Dantas-Torres and Otranto, 2014). 
In the 19th century, arsenical solutions were 
the first substances used for control of 
ectoparasites, and were introduced in Brazil by 
1900. After the discovery of resistance 
mechanisms to ectoparasiticides, other compounds 
were developed, such as 
dichlorodiphenyltrichloroethane (DDT), 
hexachlorocyclohexane (HCH), toxaphene e 
dieldrin. From 1941, new acaricidal compounds 
have been synthesized, such as organophosphates, 
organochlorides, carbamates, and pyrethroids 
(Sartor and Santarém, 2006). 
Chlordimeform, the first formamidine, 
appeared in 1963 (Hollingworth, 1976), followed 
by other drugs such as amitraz, or N’- (2,4-
dimethylphenyl)-N-[(2,4-imethylphenyl) imino-
methyl] -N-methylmehtanimidamide, of molecular 
formula C19H23N3 (Pubchem, 2015), in England 
in 1969 (Hollingworth, 1976). This is the most used 
active substance among the formamidines, 
including in Brazil, because it is the only one 
approved for animal use (Sakate et al., 1992; Sartor 
and Santarém, 2006).  
This review describes the pharmacokinetics, 
pharmacodinamics, indications, toxicological and 
pathological effects of amitraz, as well as the 
intoxication treatment and the aspects related to its 
detection in biological matrices. 
 
Pharmacokinetics and pharmacodinamics 
Amitraz is quickly hydrolyzed in an acid 
environment when it is orally administrated, due to 
its instability in this environment (Sartor and 
Santarém, 2006). The hydrolysis in a low pH 
generates the compound 2,4-dimethylphenyl 
formamide, which is stable in an acid environment. 
This substance can still be hydrolyzed, generating 
2,4-dimethylaniline (Pierpoint et al., 1997). 
Absorption is effective through the skin, which 
may be major or minor depending on its integrity, 
the occurrence of injuries, and inflammation. After 
reaching the blood stream, the drug reaches the 
highest plasmatic level in up to two hours 
(Dallegrave and Sebben, 2008). The 
biotransformation occurs in the liver, generating 
the active metabolite BTS 27271, the most 
important pharmacologically (Santarém et al., 
2008), because it acts directly in the regulation of 
the insulin and glucagon secretion by binding to the 
α2A and α2D-adrenergic receptors, inhibiting 
insulin and stimulating glucagon secretion, 
resulting in hyperglycemia (Abu-Basha et al., 
1999). Metabolites are excreted in bile and urine 
(Sartor and Santarém, 2006; Santarém et al., 2008). 
In insects, formamidines such as 
chlordimeform and amitraz operate its toxic effects 
by interacting with octopaminergic receptors in the 
central nervous system (Evans and Gee, 1980; 
Chen et al., 2007). The mechanisms by which the 
deleterious effects of amitraz in mammals are 
determined are based on its agonistic action on α2-
adrenergic receptors and inhibitory action over the 
monoamine oxidase (MAO), but there are reports 
of various action pathways, such as: H1 histamine 
receptor inhibition, prostaglandin synthase 
inhibition, adenylyl cyclase inhibition, voltage-
gated calcium channels activation, reactive oxygen 
species generation, cell death induction and 
endocrine disruptions. Amitraz is also related to the 
emergence of neurotoxic effects and modifications 
in the reproductive sphere in rats (Del Pino et al., 
2015). 
 
Indications and contraindications 
Amitraz is indicated for animal use against 
mites, lice and ticks for cattle, swine and sheep. For 
dogs, it is used against ticks and mite (Sartor and 
Santarém, 2006). It was reported as the drug of 
choice in the treatment of localized and generalized 
demodicosis in dogs (Folz et al., 1984). Along with 
macrocyclic lactones such as milbemycin oxime, 
ivermectin, moxidectin, and doramectin, amitraz is 
still recommended for the treatment of generalized 
canine demodicosis, although it is not very efficient 
in adult-onset demodicosis cases (Mueller, 2004; 
Mueller et al., 2012). Cowan and Campbell (1988) 
and Chesney (1989) also reported the use of 
amitraz in the treatment of demodicosis in cats. 
Gunaratnam et al. (1983) evaluated amitraz 
toxicity in cats, and concluded that low 
concentrations, around 0,0125% are capable of 
generating moderate toxic effects, especially 
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anorexia. The toxic effects are even more evident 
in cats, due to their licking habit, resulting in a 
higher intake of the product. However, it is possible 
to use amitraz topically in healthy cats, respecting 
the appropriate contraindications common to the 
other species, which is to avoid the use in diabetic, 
hypothermic, and cardiac patients (Andrade et al., 
2007). 
Amitraz is contraindicated in horses due to 
the risk of hypomotility and intestinal atony, 
leading to severe intestinal impaction (Duarte et al., 
2003; Santarém et al., 2008). Duarte et al. (2003) 
observed, besides the intestinal symptoms, the 
occurrence of neurologic signs as drowsiness, 
decreased cranial nerve reflexes and ataxia in 
horses submitted to the experimental use of 
amitraz. This substance is contraindicated for 
patients with extended skin injuries, which could 
lead to an over absorption, favoring intoxication 
(Santarém et al., 2008).  
Toxicological and pathological aspects of 
amitraz poisoning in animals  
In Brazil, data provided by the Sistema 
Nacional de Informações Tóxico-Farmacológicas 
(SINITOX) showed that in the year of 2013, 42128 
cases of human intoxications and 255 cases of 
animal intoxications of any etiologies were 
registered (Fiocruz, 2013a). Veterinary products 
were responsible for the notification of 307 cases 
of human intoxications and 7 cases of animal 
intoxications in the same year (Fiocruz, 2013b). 
However, these numbers may be even higher, due 
to a high rate of underreported cases by the Centro 
de Informação e Assistência Toxicológica (CIAT) 
of each Brazilian state (Fiocruz, 2013). 
Several studies about amitraz acute toxicity 
were previously conducted in many species, 
regarding the median lethal dose 50 (LD50) (Table 
1).
 
Table 1. Oral LD50 values for dog, mouse, rat and chick. 
Species LD50 Authors 
Mouse >1600 mg/kg Al-Thani et al. (2003) 
Rat 515 - 938 mg/kg Dallegrave and Sebben (2008) 
Dog 100 mg/kg. Intoxication signs at doses of 20 mg/kg. Dallegrave and Sebben (2008) 
Chick 53,05 mg/kg Al-Hammdani and Al-Baggou (2014) 
 
 
Amitraz intoxication has been reported in 
dogs, and the clinical signs are evidenced in 
nervous, digestive, cardiovascular, and urinary 
systems (Oglesby et al., 2006) and include 
sedation, bradycardia, bradyarrhythmias, 
hypotension, bradypnea, transitory hyperglycemia, 
mydryasis, and hypothermia, cats being more 
sensitive than dogs regarding these last signs 
(Andrade et al, 2008). Emesis, diarrhea, abdominal 
pain, and intestinal hypomotility are observed in 
the digestive system. In the urinary system, there is 
polyuria (Xavier et al., 2008). It is the stimulation 
of α2-adrenergic receptors that generates the main 
signs of amitraz poisoning, such as loss of 
consciousness, breathing depression, seizures, 
bradycardia, hypotension, and hypothermia 
(Proudfoot, 2003). 
Electrocardiographic changes have been 
reported after the experimental use of amitraz in 
healthy dogs. Right after the intravenous 
administration of amitraz, there was a reduction in 
the duration of the P wave and an increase in the 
length of QT, PT, and RR intervals, but without 
changes in the QRS complex and in the amplitude 
of the R wave, besides a marked bradycardia. 
These results are consistent with the α2-agonistic 
action of amitraz, but there were no sinoatrial 
blocks, as expected (Farias et al., 2005). In a 
different study, the cardiovascular and respiratory 
effects after the intravenous administration of 
amitraz in dogs, in increasing doses of 1, 2 and 5 
mg/kg were reported. Thus, an increase in blood 
pressure during one hour and an initial bradycardia 
were observed, which returned to normal levels in 
a dose-dependent way. The tidal volume, the 
respiratory rate, and the respiratory volume per 
minute presented an initial drop. On the other hand, 
hyperventilation was observed after the use of high 
doses of amitraz (Cullen and Reynoldson, 1987).  
Accidental poisoning with amitraz was 
described in two Simmental cows. The animals 
received accidental intramuscular injections of 
amitraz, and among the clinical signs, anorexia, 
depression, reduced rumen motility, congestion of 
episcleral vessels, light bloat, and loss of pupillary 
reflex were observed. Heart and respiratory rates 
and rectal temperature remained unchanged. The 
poisoning was treated with yohimbine, and after 24 
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hours, the animals were clinically stable (Kizil et 
al., 2008). 
In a study on the acute intoxication by 
amitraz in mice, the histopathological findings 
after the oral administration of growing doses of 
both the technical and commercial formulations of 
amitraz in two distinct groups were analyzed. It 
was observed that the groups that received doses 
equal or higher than 1500 mg/kg of the technical 
formulation presented degenerative hepatic 
changes. At a dose of 1500 mg/kg, there was 
hydropic degeneration; at 1800 mg/kg, both 
hidropic and fatty degeneration; at 2200 mg/kg and 
2500 mg/kg, there were severe degenerative 
injuries. Similar injuries were seen in animals who 
received the commercial formulation, but at a dose 
equal or higher than 250 mg/kg. This kind of 
formulation also led to the development of 
epithelial cell necrosis at a dose of 500 mg/kg, and 
at the doses of 750 mg/kg and 1000 mg/kg, tubular 
epithelial cells necrosis was observed (Filazi et al., 
2004). 
Omoja et al. (2016a) evaluated the hepatic 
and renal effects of the subchronical administration 
of a commercial formulation of amitraz 12.5% in 
albinoWistar rats for 84 days. Four experimental 
groups were designated, whose doses corresponded 
to 10 mg/kg, 2 mg/kg, and 0.4 mg/kg, and the 
fourth group received 10 ml/kg of water, by oral 
route. The group treated with 10 mg/kg presented 
moderate hepatic vacuolar degeneration of 
periportal hepatocytes and mild to moderate 
generalized tubular degeneration in kidneys, 
affecting pars recta, proximal convoluted tubules, 
and collecting tubules. The remaining groups 
didn’t show any significant changes. This way, it 
can be inferred that the chronic use of amitraz in 
high doses may provoke severe damages to the 
hepatic and renal tissues. Through the same 
protocol, Omoja et al. (2017) also observed that 
rats exposed to a 10 mg/kg dose, given daily by oral 
route may present regenerative anemia by the 30th 
day of treatment, analyzed by the mean levels of 
packed cell volume, red blood cell and total white 
blood cell counts, and hemoglobin. 
The amitraz toxicity related to the 
reproductive sphere was evaluated in rats, which 
received orally growing doses of the drug (40, 120, 
and 360 ppm). Significant changes were observed 
only after a 360 ppm dose, in which there was a 
decrease in the seminal vesicles’ weight, decrease 
of sperm motility, fewer living offspring, and  
increased losses after deployment (Lim et al.,  
2010). Omoja et al. (2016b) also investigated the 
reproductive effects in male Wistar rats sub-
chronically exposed to growing doses of amitraz by 
oral route, and concluded that there is a dose-
dependent influence of amitraz over testosterone 
production and sperm reserve, besides the 
appearance of testicular degeneration in the group 
treated with a dose of 10 mg/kg/day. 
In a case report of accidental poisoning with 
amitraz in a dog, which resulted in the death of the 
animal, the main post mortem findings were 
pulmonary edema, hemorrhagic gastroenteritis, 
cardiac, pulmonary, renal, hepatic and splenic 
hemorrhages, and also brain congestion and edema 
(Andrade et al., 2004).  
In a second case of accidental poisoning in a 
dog by ingestion of a bait containing amitraz, the 
necropsy revealed severe ventral subcutaneous 
edema and moderate serosanguineous ascites, 
diffuse hemorrhage on the left kidney and partial 
on the right kidney. Histopathological analysis of 
the kidney showed severe diffuse cortical 
hemorrhage, obliterating the interstitial tissue; 
glomerular and tubular necroses were also evident, 
besides a neutrophilic infiltration due to the 
necrosis. The cells presented intense eosinophilia, 
unbundling of the basal membrane, karyolysis and 
pyknotic nuclei. Yet, there were certain multifocal 
deposits of fibrin, severe cortical vessel congestion 
and moderate congestion in the medulla. 
Histopathological analysis of the liver revealed 
severe congestion and sinusoidal enlargement, 
hepatocyte atrophy, multifocal fatty degeneration, 
and some necrotic areas (Oglesby et al., 2006).  
 
Treatment 
The reversion of amitraz poisoning in 
animals is based on the supportive therapy, 
gastrointestinal decontamination, and the use of 
α2-adrenoceptor antagonists such as yohimbine 
(Andrade et al., 2005; Smerdel et al., 2008) and 
atipamezole (Hugnet et al., 1996; Andrade et al., 
2005). Yohimbine is reported for reversing the 
alterations caused by amitraz administration in 
high concentrations, such as hypotension, 
bradycardia, emesis, salivation, mydriasis, 
moderate sedation, hyperglycemia, and in some 
cases, synusal arrhythmia (Smerdel et al., 2008). 
Atipamezole is a potent selective α2-adrenoceptor 
antagonist, not interacting with other receptors. It 
is a great antagonist of xylazine and medetomidine,  
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drugs known for their agonistic activity on α2-
adrenergic receptors, as is amitraz (Cardoso et al., 
2011). 
 
Laboratory analyses 
To detect amitraz and its main metabolites, 
there are many standardized methodologies. 
According to Hugnet et al. (1996), it is possible to 
evaluate the plasmatic toxicokinetics of amitraz in 
dogs by high-performance thin layer 
chromatography (HPTLC), an easily reproducible 
technique. Zanella et al. (1999) quantified amitraz 
in ectoparasiticide bath solutions used in cattle by 
HPLC-UV technique. This technique was effective 
for detection of amitraz in the samples, and has 
allowed quantifying the active ingredient without 
any interference from foreign substances. Saito et 
al. (2008) validated a methodology for detection of 
amitraz and its metabolites in human serum by 
liquid chromatography-mass spectrometry (LC-
MS), using monolithic silica column with 
acetonitrile. Marafon et al. (2010) seek to 
standardize and validate the technique of gas 
chromatography with thermionic sensitive 
detection (GC-TSD), and thus determine the 
amitraz concentration in the blood of cats 
experimentally submitted to ectoparasiticide 
dipping baths of amitraz 0.4%. This technique 
comes in use to determine the pharmacokinectics 
of amitraz in cats. GUO et al. (2014) developped 
an analitical methodology for amitraz and its 
metabolites N-[2,4-(dimethylphenyl) -N’-methyl-
formamidine, 2,4-dimethylformamidine e 2,4-
dimethylaniline in human blood samples, by solid 
phase extraction (SPE) and liquid chromatography-
tandem mass spectrometry. This methodology was 
effective, sensitive, selective, and reproducible to 
detect and analyze amitraz and its metabolites in 
blood samples. 
 
Conclusion 
Due to its high efficacy against a wide range 
of ectoparasites in livestock and pet animals, 
amitraz is a common product in veterinary 
practices and homes. As a result, both accidental 
and intentional poisoning in animals and humans is 
currently underreported and requires wider 
attention from both medical and veterinary 
practitioners.  
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